Pharma Mar SA (PHM) Stock Price & News

PHM:BME

Pharma Mar SA

€69.25

+1.17%

(+0.80) 1D

Oct 20, 5:36:00 PM GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Next call in 6 days

Tue, Oct 27, 9:00 AM

Fiscal period

Q3 2026

- / €0.00

Revenue / Est. (EUR)

- / 46.80M

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	35.66M	90.48M	42.90M	49.60M
Cost of goods sold	2.30M	3.77M	3.66M	4.73M
Cost of revenue	2.30M	3.77M	3.66M	4.73M
Research and development expenses	22.13M	25.59M	20.88M	26.38M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.63M	17.31M	15.31M	17.12M
Operating expense	37.32M	43.09M	38.62M	46.28M
Total operating expenses	39.62M	46.87M	42.28M	51.01M
Operating income	-3.96M	43.61M	622.00K	-1.40M
Other non operating income	-	-	-	-
EBT including unusual items	-4.08M	44.28M	1.60M	-993.00K
EBT excluding unusual items	-4.08M	44.28M	1.60M	-993.00K
Income tax expense	24.00K	-15.39M	65.00K	-21.00K
Effective tax rate	-0.59%	-34.75%	4.07%	2.11%
Other operating expenses	8.56M	195.00K	2.43M	2.77M
Net income	-4.10M	59.66M	1.53M	-972.00K
Net profit margin	-11.50%	65.95%	3.57%	-1.96%
Earnings per share	-	-	-	-
Interest and investment income	-	3.44M	976.00K	412.00K
Interest expense	-117.00K	-724.00K	-	-
Net interest expenses	-117.00K	2.72M	976.00K	412.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.95M	45.64M	2.71M	700.00K
Gain or loss from assets sale	-10.00K	-754.00K	-	-

Finance